Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleDynamic susceptibility contrast MRI measures of relative cerebral blood volume continue to show promise as an early response marker in the setting of bevacizumab treatment.AuthorsBoxerman, Jerrold L.; Schmainda, Kathleen M.; Zheng Zhang; Barboriak, Daniel P.; Pope, Whitney B.PublicationNeuro-Oncology, 2015, Vol 17, Issue 11, p1538ISSN1522-8517Publication typeArticleDOI10.1093/neuonc/nov163